EverNov Medicines (Zhuhai Hengqin) Co., Ltd
1 clinical trials · Sponsor
◉ Watch EverNov Medicines (Zhuhai Hengqin) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors (NCT04699643) | EverNov Medicines (Zhuhai Hengqin) Co., Ltd | 2020-07-30 |
Track EverNov Medicines (Zhuhai Hengqin) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.